Nestle's Prospects To Lead OTC Acne Market Gel With Differin Approval
This article was originally published in The Pink Sheet
Executive Summary
Differin Gel, the first NDA approved OTC acne treatment, could make Nestle the runaway leader in the market. The Swiss firm's Nestle Skin Health business owns Differin maker Galderma and has a majority stake in a JV marketing Proactiv.